Vise Technologies, Inc. Pfizer Inc Transaction History

Vise Technologies, Inc.

$771 Million
Q3 2024

A detailed history of Vise Technologies, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Vise Technologies, Inc. holds 68,089 shares of PFE stock, worth $1.8 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

68,089

Previous 51,452 32.33%

Holding current value

$1.8 Million

Previous $1.44 Million 36.9%

% of portfolio

0.26%

Previous 0.26%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$27.7 - $31.39 $460,844 - $522,235	16,637 Added 32.33%	68,089 $1.97 Million
Q2 2024 Aug 01, 2024	BUY	$25.26 - $29.6 $113,063 - $132,489	4,476 Added 9.53%	51,452 $1.44 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $204,453 - $234,777	-7,897 Reduced 14.39%	46,976 $1.3 Million
Q4 2023 Feb 07, 2024	SELL	$26.13 - $33.94 $345,125 - $448,279	-13,208 Reduced 19.4%	54,873 $1.58 Million
Q3 2023 Oct 31, 2023	BUY	$32.09 - $37.51 $94,825 - $110,842	2,955 Added 4.54%	68,081 $2.26 Million
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $30,160 - $34,894	835 Added 1.3%	65,126 $2.39 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $642,214 - $836,069	16,304 Added 33.98%	64,291 $2.62 Million
Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $335,837 - $438,398	8,044 Added 20.14%	47,987 $2.46 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $585,465 - $714,706	13,379 Added 50.37%	39,943 $1.75 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $521,368 - $618,179	11,205 Added 72.95%	26,564 $1.39 Million
Q1 2022 Jun 08, 2022	BUY	$45.75 - $56.69 $702,674 - $870,701	15,359 New	15,359 $795,000

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vise Technologies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vise Technologies, Inc. with notifications on news.

Account

Vise Technologies, Inc. Pfizer Inc Transaction History